Insufficient scRNA-seq data for expression of TSLP at single-cell level.
Insufficient scRNA-seq data for expression of TSLP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 476.31 | 244 / 245 | 61% | 1.71 | 306 / 502 |
esophagus | 100% | 277.38 | 1441 / 1445 | 56% | 2.07 | 102 / 183 |
lung | 98% | 196.57 | 564 / 578 | 40% | 1.57 | 462 / 1155 |
uterus | 88% | 81.24 | 150 / 170 | 48% | 1.93 | 222 / 459 |
liver | 100% | 312.22 | 226 / 226 | 36% | 0.92 | 146 / 406 |
bladder | 100% | 335.43 | 21 / 21 | 28% | 1.44 | 139 / 504 |
adrenal gland | 80% | 67.31 | 207 / 258 | 33% | 1.31 | 76 / 230 |
breast | 99% | 171.21 | 456 / 459 | 10% | 0.20 | 112 / 1118 |
intestine | 97% | 117.24 | 937 / 966 | 12% | 0.25 | 65 / 527 |
thymus | 80% | 61.32 | 522 / 653 | 28% | 0.93 | 168 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.10 | 1 / 1 |
blood vessel | 99% | 139.81 | 1321 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 144.23 | 1179 / 1204 | 0% | 0 | 0 / 0 |
skin | 88% | 115.00 | 1596 / 1809 | 8% | 0.24 | 38 / 472 |
heart | 95% | 205.92 | 819 / 861 | 0% | 0 | 0 / 0 |
muscle | 88% | 66.05 | 704 / 803 | 0% | 0 | 0 / 0 |
stomach | 74% | 112.67 | 266 / 359 | 9% | 0.17 | 26 / 286 |
kidney | 66% | 50.62 | 59 / 89 | 16% | 0.99 | 146 / 901 |
tonsil | 0% | 0 | 0 / 0 | 71% | 2.03 | 32 / 45 |
spleen | 58% | 37.30 | 140 / 241 | 0% | 0 | 0 / 0 |
pancreas | 5% | 2.25 | 17 / 328 | 44% | 0.91 | 79 / 178 |
ovary | 43% | 26.98 | 77 / 180 | 3% | 0.05 | 12 / 430 |
brain | 26% | 13.02 | 675 / 2642 | 15% | 0.30 | 108 / 705 |
eye | 0% | 0 | 0 / 0 | 18% | 0.34 | 14 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.12 | 2 / 29 |
peripheral blood | 6% | 4.38 | 60 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033005 | Biological process | positive regulation of mast cell activation |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_1904894 | Biological process | positive regulation of receptor signaling pathway via STAT |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0001961 | Biological process | positive regulation of cytokine-mediated signaling pathway |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0038111 | Biological process | interleukin-7-mediated signaling pathway |
GO_0032754 | Biological process | positive regulation of interleukin-5 production |
GO_0071654 | Biological process | positive regulation of chemokine (C-C motif) ligand 1 production |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0071657 | Biological process | positive regulation of granulocyte colony-stimulating factor production |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005139 | Molecular function | interleukin-7 receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | TSLP |
Protein name | Thymic stromal lymphopoietin |
Synonyms | |
Description | FUNCTION: [Isoform 1]: Cytokine that induces the release of T-cell-attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c(+) dendritic cells. Can induce allergic inflammation by directly activating mast cells. .; FUNCTION: [Isoform 2]: May act as an antimicrobial peptide in the oral cavity and on the skin. . |
Accessions | Q969D9 ENST00000379706.4 [Q969D9-2] ENST00000420978.6 ENST00000344895.4 [Q969D9-1] A0A0C4DG43 |